about
Biochemical characterization and crystal structure of a recombinant hen avidin and its acidic mutant expressed in Escherichia coliProteomic analysis of a nutritional shift-up in Saccharomyces cerevisiae identifies Gvp36 as a BAR-containing protein involved in vesicular traffic and nutritional adaptation.Detergent enhancement of on-tissue protein analysis by matrix-assisted laser desorption/ionization imaging mass spectrometry.Expanding the proteome two-dimensional gel electrophoresis reference map of human renal cortex by peptide mass fingerprinting.Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET.Mutations of the CK2 phosphorylation site of Sic1 affect cell size and S-Cdk kinase activity in Saccharomyces cerevisiae.Expression of heat shock protein 27 in human renal cell carcinoma.A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI DataMutual information optimization for mass spectra data alignment.Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes.Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis.Detection of high molecular weight proteins by MALDI imaging mass spectrometry.Imaging mass spectrometry: a new tool for kidney disease investigations.Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach.MALDI imaging mass spectrometry in glomerulonephritis: feasibility study.Proteomics for the diagnosis of thyroid lesions: preliminary report.A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues.Tumor size, stage and grade alterations of urinary peptidome in RCC.Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.Machine learning approaches in MALDI-MSI: clinical applications.Implementation of proteomic biomarkers: making it work.MALDI-MSI Analysis of Cytological Smears: The Study of Thyroid Cancer.Proteomic knowledge of human aquaporins.AQP1 expression analysis in human diseases: implications for proteomic characterization.Proteomics and nephrology.The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques.Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative.Proteome analysis in thyroid pathology.Urinary proteomics for the study of genetic kidney diseases.The putative role of MALDI-MSI in the study of Membranous Nephropathy.The proteomic landscape of renal tumors.Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast.Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions.Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms.Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells.
P50
Q27765625-523F9674-3BD0-429D-9C17-79F8CC67A83EQ27938042-ED0E85D0-8A6B-4FB3-8BC8-06058CF8E471Q30431080-C219F612-1E5E-4132-BBDB-9FAE796837F1Q30776483-95C2798C-FA31-4EDD-8801-CE07C0A9F996Q31005426-F936E535-8372-4CF2-ADB8-283261DD7F3CQ31039792-89F925E6-6C5C-46C8-9DE8-BE32CF9EC91AQ31099416-DF1BC4D2-2719-40AA-95C5-440B9C6CCA2CQ31107562-929E9221-D87D-41E9-A07D-9266A8D41D2BQ33881800-B0C5BC3C-E2DA-4110-BCFC-D73EF4FAB2C1Q33962458-27B5C3F5-8598-42B5-B21F-80D8E51A0023Q34155959-EE085FD6-577D-42B1-8AED-F8FF64C971A8Q34208607-C87DB4F9-41DE-4EC1-B7EA-38428B5E8902Q34367975-79E730A4-DF3E-440C-81EA-BEB9CB4A064EQ34542887-AE077F53-B9C5-429F-9390-B86EADF84A32Q34557652-B475C4D6-69DA-4315-A664-770E4F768E44Q34647241-A95111D9-7E18-40F3-B0AD-96D2ABABF67CQ34843763-8E570855-40BF-45EF-9FB8-F711ABD2DFEDQ35054439-29DF6F4E-AF32-44C5-A323-20ADFFEB75C1Q35209446-2C9626A0-E487-4CD4-8B72-F569734BAA09Q35543504-3A76F4FF-DAE5-407C-A161-97147FAEA1CEQ35813526-4FF44D75-3149-4860-8091-4102208553BCQ35862682-8900A5D8-8FB7-42DD-8146-2BE06A7D6940Q36056901-0B2D0216-62A4-4C55-8C1A-D366E435D4BBQ36297774-6B7B4FC8-E757-4326-AB82-598A0DC7BE99Q36376227-9DADC2CD-FDC8-4BCB-AE5E-7AF512342B1CQ36624645-55F7D5AF-517D-42E4-9F3F-910002E9A741Q37087372-F94D4004-6B2E-4E55-879B-4C21B9E33543Q38050071-C0E5C5F5-A3C3-4909-BF30-DA0E1C6BBFA9Q38217103-79720E2B-D3C4-43E8-AF48-AAB77FFC9A53Q38371839-FC392B99-8C2F-42F2-80D3-DF49816E3092Q38541463-29D77B44-8DD2-4BEA-B04F-A0CCC5F08135Q38677349-604E6E6C-E793-421E-8F3F-4A5F598ED52BQ38790253-C42E3297-A580-4E62-9ECE-0451EAB89D3FQ38803559-1B6CBD12-C4F5-44F9-8674-E5A4CEE99106Q39681263-5FAFC23E-8441-4869-BC26-FC09E09488F6Q39876845-5D988E97-62A2-4D16-A132-488F338C6421Q40364366-0E1423BF-F21A-482F-9544-CF561BE79F40Q40439734-754041CD-F45E-4A94-97B0-A4CF7629A78AQ40844552-F72C3DAA-39F9-4FC5-8566-3909C2B02ECEQ40870496-D08CC787-0ABE-41F3-BCE5-DCD2E36703F7
P50
description
farmacoloog
@nl
hulumtues
@sq
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Fulvio Magni
@ast
Fulvio Magni
@en
Fulvio Magni
@es
Fulvio Magni
@sl
type
label
Fulvio Magni
@ast
Fulvio Magni
@en
Fulvio Magni
@es
Fulvio Magni
@sl
prefLabel
Fulvio Magni
@ast
Fulvio Magni
@en
Fulvio Magni
@es
Fulvio Magni
@sl
P227
P244
P1053
A-7340-2014
P1153
55313718200
7006449861
P21
P214
12150686587112542327
P227
1156575427
P244
no2017123364
P31
P3829
P496
0000-0002-8663-0374
P569
1957-01-01T00:00:00Z
P734
P735
P7859
lccn-no2017123364